Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benito Velayos

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Endoscopy International Open|June 4, 2019
Even non-experts identify non-dysplastic lesions in inflammatory bowel disease via chromoendoscopy: results of a screening program in real-lifeBeatriz Sicilia Aladrén, Yago González-Lama, María García-Alvarado, et al.
Laboratory Medicine|April 29, 2015
Early detection of high oxidative activity in patients with adenomatous intestinal polyps and colorectal adenocarcinoma: myeloperoxidase and oxidized low-density lipoprotein in serum as new markers of oxidative stress in colorectal cancerJesús Crespo-Sanjuán, María D Calvo-Nieves, Beatriz Aguirre-Gervás, et al.
Journal of Crohn'S & Colitis|April 10, 2025
Effectiveness and safety of rectal tacrolimus in patients with ulcerative colitis. TACRO-TOPIC study of GETECCUEsteban Fuentes-Valenzuela, Iria Bastón-Rey, Francisco Javier García-Alonso, et al.
Inflammatory Bowel Diseases|August 3, 2023
Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naïve Inflammatory Bowel Disease PatientsLaila Aldars-García, Rubén Gil-Redondo, Nieves Embade, et al.
The American Journal of Gastroenterology|February 4, 2025
Probiotics Prescribed With Helicobacter pylori Eradication Therapy in Europe: Usage Pattern, Effectiveness, and Safety. Results From the European Registry on Helicobacter pylori Management (Hp-EuReg)Diego Casas Deza, Javier Alcedo, Miguel Lafuente, et al.
United European Gastroenterology Journal|December 5, 2023
Role of proton pump inhibitors dosage and duration in Helicobacter pylori eradication treatment: Results from the European Registry on H. pylori managementManuel Pabón-Carrasco, Alma Keco-Huerga, Manuel Castro-Fernández, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 5, 2024
Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCUMaría José Casanova, Berta Caballol, María José García, et al.
Alimentary Pharmacology & Therapeutics|July 5, 2025
Effectiveness and Safety of First-Line Non-Bismuth Quadruple Concomitant Therapy Versus Single-Capsule Bismuth Quadruple TherapyOlga P Nyssen, Nuria Montes, Ángeles Pérez-Aísa, et al.
Gut|July 19, 2023
Bismuth quadruple three-in-one single capsule three times a day increases effectiveness compared with the usual four times a day schedule: results from the European Registry on <i>Helicobacter pylori</i> Management (Hp-EuReg)Ángeles Pérez-Aisa, Olga P Nyssen, Alma Keco-Huerga, et al.
Inflammatory Bowel Diseases|February 15, 2022
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN StudyMaría Chaparro, Iria Baston-Rey, Estela Fernández-Salgado, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Endoscopy International Open|June 4, 2019
Even non-experts identify non-dysplastic lesions in inflammatory bowel disease via chromoendoscopy: results of a screening program in real-lifeBeatriz Sicilia Aladrén, Yago González-Lama, María García-Alvarado, et al.
Laboratory Medicine|April 29, 2015
Early detection of high oxidative activity in patients with adenomatous intestinal polyps and colorectal adenocarcinoma: myeloperoxidase and oxidized low-density lipoprotein in serum as new markers of oxidative stress in colorectal cancerJesús Crespo-Sanjuán, María D Calvo-Nieves, Beatriz Aguirre-Gervás, et al.
Journal of Crohn'S & Colitis|April 10, 2025
Effectiveness and safety of rectal tacrolimus in patients with ulcerative colitis. TACRO-TOPIC study of GETECCUEsteban Fuentes-Valenzuela, Iria Bastón-Rey, Francisco Javier García-Alonso, et al.
Inflammatory Bowel Diseases|August 3, 2023
Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naïve Inflammatory Bowel Disease PatientsLaila Aldars-García, Rubén Gil-Redondo, Nieves Embade, et al.
The American Journal of Gastroenterology|February 4, 2025
Probiotics Prescribed With Helicobacter pylori Eradication Therapy in Europe: Usage Pattern, Effectiveness, and Safety. Results From the European Registry on Helicobacter pylori Management (Hp-EuReg)Diego Casas Deza, Javier Alcedo, Miguel Lafuente, et al.
United European Gastroenterology Journal|December 5, 2023
Role of proton pump inhibitors dosage and duration in Helicobacter pylori eradication treatment: Results from the European Registry on H. pylori managementManuel Pabón-Carrasco, Alma Keco-Huerga, Manuel Castro-Fernández, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 5, 2024
Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCUMaría José Casanova, Berta Caballol, María José García, et al.
Alimentary Pharmacology & Therapeutics|July 5, 2025
Effectiveness and Safety of First-Line Non-Bismuth Quadruple Concomitant Therapy Versus Single-Capsule Bismuth Quadruple TherapyOlga P Nyssen, Nuria Montes, Ángeles Pérez-Aísa, et al.
Gut|July 19, 2023
Bismuth quadruple three-in-one single capsule three times a day increases effectiveness compared with the usual four times a day schedule: results from the European Registry on <i>Helicobacter pylori</i> Management (Hp-EuReg)Ángeles Pérez-Aisa, Olga P Nyssen, Alma Keco-Huerga, et al.
Inflammatory Bowel Diseases|February 15, 2022
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN StudyMaría Chaparro, Iria Baston-Rey, Estela Fernández-Salgado, et al.
Pageof 4